Use of mometasone furoate for treating upper airway diseases
DC CAFCFirst Claim
Patent Images
1. A method of treating allergic rhinitis comprising administering once daily nasal passages 200 micrograms of mometasone furoate.
1 Assignment
Litigations
0 Petitions
Accused Products
Abstract
The administration of aerosolize particles of mometasone furoate in the form of dry powders, solutions, or aqueous suspension for treating corticosteroid-responsive diseases of the surfaces of upper and/or lower airway passages and/or lungs, e.g., allergic rhinitis and asthma is disclosed.
25 Citations
10 Claims
- 1. A method of treating allergic rhinitis comprising administering once daily nasal passages 200 micrograms of mometasone furoate.
- 8. A method of treating a disease comprising allergic rhinitis, comprising administering once daily to nasal passages an aqueous nasal spray comprising mometasone furoate monohydrate, in an amount providing about 100 micrograms of mometasone furoate to each nostril.
-
10. A method of treating a disease comprising allergic rhinitis, comprising administering once daily to nasal passages an aqueous nasal spray comprising mometasone furoate monohydrate, in an amount providing about 50 micrograms of mometasone furoate to each nostril.
Specification